3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Endocrine
2
Conditions
Pheochromocytoma
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Adrenocortical Adenoma
1
Adrenal incidentaloma
1
Interventions
pembrolizumab
589
Cyclophosphamide
539
Magnetic Resonance Spectroscopy
523
Radiotherapy
506
Specimen Handling
503
Nivolumab
407
Cisplatin
370
Carboplatin
358
Biopsy
304
Blood Specimen Collection
295
Radiosurgery
283
Paclitaxel
274
Surveys and Questionnaires
268
Standard of Care
266
Gemcitabine
265
fludarabine
261
Dexamethasone
258
Drug Therapy
256
venetoclax
246
Bevacizumab
246
Oxaliplatin
206
Rituximab
195
Capecitabine
194
Radiation
189
Fluorouracil
186
Ipilimumab
184
durvalumab
180
Doxorubicin
175
atezolizumab
172
Etoposide
171
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Adrenalectomy
×
1 year
×
Clear all
NCT07470580
2026-03-13
ADERADHTA2
University Hospital, Toulouse
Phase NA
Not yet recruiting
134 enrolled
NCT07200245
2025-10-01
HEMODYNAMICS
Central Hospital, Nancy, France
Not yet recruiting
522 enrolled